A cytotoxic ribonuclease targeting specific transfer RNA anticodons

Area of Science:

• Molecular Biology
• Biochemistry
• Microbiology

Background:

• Colicins are bacteriocins produced by Escherichia coli that inhibit the growth of related strains.
• The carboxyl-terminal domain of colicin E3 is known to inhibit protein synthesis by degrading ribosomal RNA.
• The specific molecular targets of colicin E5 were not previously well-defined.

Purpose of the Study:

• To elucidate the molecular mechanism by which the carboxyl-terminal domain of colicin E5 inhibits protein synthesis.
• To identify the specific cellular targets of colicin E5 within Escherichia coli.

Main Methods:

• In vivo and in vitro biochemical assays were employed to investigate colicin E5 activity.
• Analysis of transfer RNA (tRNA) cleavage patterns in the presence of colicin E5.

Main Results:

• The carboxyl-terminal domain of colicin E5 was found to inhibit protein synthesis in Escherichia coli.
• Unlike colicin E3, colicin E5 targets specific transfer RNAs (tRNAs) for Tyrosine, Histidine, Asparagine, and Aspartic acid.
• These targeted tRNAs contain the modified base, queuine, at the anticodon wobble position.
• Colicin E5 specifically hydrolyzes these tRNAs on the 3' side of the queuine nucleotide.
• A strong correlation exists between colicin E5 toxicity and the cleavage of these specific intracellular tRNAs.

Conclusions:

• The primary target of colicin E5 is not ribosomes, but rather a specific subset of transfer RNAs (tRNAs) containing queuine.
• The cleavage of these queuine-containing tRNAs by colicin E5 is responsible for its protein synthesis inhibition and toxicity.